首页> 外文期刊>Diabetes >Bcl-2-Modifying Factor Induces Renal Proximal Tubular Cell Apoptosis in Diabetic Mice
【24h】

Bcl-2-Modifying Factor Induces Renal Proximal Tubular Cell Apoptosis in Diabetic Mice

机译:Bcl-2-修饰因子诱导糖尿病小鼠肾近端肾小管细胞凋亡

获取原文
获取原文并翻译 | 示例
       

摘要

This study investigated the mechanisms underlying tubular apoptosis in diabetes by identifying proapoptotic genes that are differentially upregulated by reactive oxygen species in renal proximal tubular cells (RPTCs) in models of diabetes. Total RNAs isolated from renal proximal tubules (RPTs) of 20-week-old heterozygous db/m+, db/db, and db/db catalase (CAT)-transgenic (Tg) mice were used for DNA chip microarray analysis. Real-time quantitative PCR assays, immunohistochemistry, and mice rendered diabetic with streptozotocin were used to validate the proapoptotic gene expression in RPTs. Cultured rat RPTCs were used to confirm the apoptotic activity and regulation of proapoptotic gene expression. Additionally, studies in kidney tissues from patients with and without diabetes were used to confirm enhanced proapoptotic gene expression in RPTs. Bcl-2-modifying factor (Bmf) was differentially upregulated (P < 0.01) in RPTs of db/db mice compared with db/m+ and db/db CAT-Tg mice and in RPTs of streptozotocin-induced diabetic mice in which insulin reversed this finding. In vitro, Bmf cDNA overex-pression in rat RPTCs coimmunoprecipated with Bcl-2, enhanced caspase-3 activity, and promoted apoptosis. High glucose (25 mmol/L) induced Bmf mRNA expression in RPTCs, whereas rotenone, catalase, diphenylene iodinium, and apocynin decreased it. Knockdown of Bmf with small interfering RNA reduced high glucose-induced apoptosis in RPTCs. More important, enhanced Bmf expression was detected in RPTs of kidneys from patients with diabetes. These data demonstrate differential upregulation of Bmf in diabetic RPTs and suggest a potential role for Bmf in regulating RPTC apoptosis and tubular atrophy in diabetes.
机译:这项研究通过确定糖尿病模型中肾近端肾小管细胞(RPTC)中活性氧差异上调的促凋亡基因,研究了糖尿病肾小管凋亡的机制。从20周龄的杂合db / m +,db / db和db / db过氧化氢酶(CAT)-转基因(Tg)小鼠的肾近端小管(RPT)中分离的总RNA用于DNA芯片微阵列分析。实时定量PCR分析,免疫组织化学和链脲佐菌素治疗糖尿病的小鼠被用于验证RPTs中促凋亡基因的表达。培养的大鼠RPTCs用于证实细胞凋亡活性和促凋亡基因表达的调节。另外,在患有和不患有糖尿病的患者的肾脏组织中进行的研究被用于证实RPT中促凋亡基因表达的增强。与db / m +和db / db CAT-Tg小鼠相比,db / db小鼠的RPT中Bcl-2-修饰因子(Bmf)差异上调(P <0.01),链脲佐菌素诱导的糖尿病小鼠的RPT中Bcl-2-修饰因子(Bmf)升高这个发现。在体外,大鼠RPTC中Bmf cDNA过表达与Bcl-2共免疫沉淀,增强caspase-3活性,并促进细胞凋亡。高葡萄糖(25 mmol / L)诱导RPTC中Bmf mRNA的表达,而鱼藤酮,过氧化氢酶,联苯二碘和载脂蛋白的含量降低。用小干扰RNA敲低Bmf减少了RPTC中高糖诱导的凋亡。更重要的是,在糖尿病患者肾脏的RPT中检测到Bmf表达增强。这些数据证明了糖尿病RPT中Bmf的差异上调,并提示Bmf在调节RPTC凋亡和糖尿病肾小管萎缩中的潜在作用。

著录项

  • 来源
    《Diabetes》 |2012年第2期|p.474-484|共11页
  • 作者单位

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Research Centre, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada;

    Pediatric Nephrology Unit, Massachusetts General Hospital,Harvard Medical School, Boston, Massachusetts;

    Nephrology/Intemal Medicine,Center for Computational Medicine and Bioinformatics, University of Michigan,Ann Arbor, Michigan;

    Nephrology/Intemal Medicine,Center for Computational Medicine and Bioinformatics, University of Michigan,Ann Arbor, Michigan;

    Division of Nephrology, Institute of Physiology,University Hospital of Zurich, University of Zurich, Zurich, Switzerland;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

    Centre de recherche du Centre hospitalier de l'Universite de Montreal (CRCHUM), Hotel-Dieu Hospital, Universite de Montreal, Montreal, Quebec,Canada;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:28

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号